|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
11.06(B) |
Last
Volume: |
666,758 |
Avg
Vol: |
474,971 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
1,636 |
25,558 |
49,996 |
92,833 |
Total Sell Value |
$374,194 |
$6,377,856 |
$11,292,577 |
$21,658,880 |
Total People Sold |
2 |
6 |
6 |
8 |
Total Sell Transactions |
2 |
10 |
16 |
28 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Johst David P |
Corporate Executive VP |
|
2019-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
21,894 |
218,387 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2019-01-30 |
4 |
D |
$119.39 |
$164,161 |
D/D |
(1,375) |
22,185 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2019-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,561 |
23,560 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2019-01-30 |
4 |
D |
$119.39 |
$457,622 |
D/D |
(3,833) |
18,144 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2019-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
11,402 |
18,144 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2019-01-30 |
4 |
D |
$119.39 |
$291,789 |
D/D |
(2,444) |
26,745 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2019-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,209 |
29,189 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-01-30 |
4 |
D |
$119.39 |
$3,476,637 |
D/D |
(29,120) |
275,071 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
68,420 |
304,191 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-01-08 |
4 |
AS |
$115.00 |
$2,875,000 |
D/D |
(25,000) |
235,771 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2018-12-10 |
4 |
AS |
$126.62 |
$504,523 |
D/D |
(3,981) |
299,204 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2018-12-10 |
4 |
AS |
$127.85 |
$470,416 |
D/D |
(3,668) |
287,748 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2018-12-10 |
4 |
AS |
$127.30 |
$467,555 |
D/D |
(3,668) |
291,416 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2018-12-10 |
4 |
AS |
$126.84 |
$523,650 |
D/D |
(4,120) |
295,084 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2018-12-10 |
4 |
AS |
$128.65 |
$255,252 |
D/D |
(1,977) |
285,771 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2018-12-10 |
4 |
AS |
$125.76 |
$428,690 |
D/D |
(3,401) |
307,493 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2018-12-10 |
4 |
OE |
$73.70 |
$1,851,565 |
D/D |
25,123 |
310,894 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2018-12-10 |
4 |
AS |
$126.24 |
$544,567 |
D/D |
(4,308) |
303,185 |
|
- |
|
Bertolini Robert J |
Director |
|
2018-12-04 |
4 |
S |
$134.19 |
$148,179 |
D/D |
(1,100) |
25,336 |
|
- |
|
Bertolini Robert J |
Director |
|
2018-12-04 |
4 |
S |
$133.16 |
$460,154 |
D/D |
(3,440) |
26,436 |
|
- |
|
Bertolini Robert J |
Director |
|
2018-12-04 |
4 |
OE |
$33.93 |
$154,042 |
D/D |
4,540 |
29,876 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2018-11-12 |
4 |
S |
$134.40 |
$250,961 |
D/D |
(1,866) |
10,575 |
|
- |
|
Johst David P |
Corporate Executive VP |
|
2018-11-07 |
4 |
AS |
$136.00 |
$3,176,416 |
D/D |
(23,356) |
196,493 |
|
- |
|
Johst David P |
Corporate Executive VP |
|
2018-11-07 |
4 |
OE |
$59.41 |
$1,387,580 |
D/D |
23,356 |
219,849 |
|
- |
|
Kochevar Deborah Turner |
Director |
|
2018-09-04 |
4 |
S |
$123.23 |
$502,799 |
D/D |
(4,066) |
6,424 |
|
- |
|
1200 Records found
|
|
Page 27 of 48 |
|
|